FAQ
Log In
Wednesday 7th December 2016
News
 › 
 › 

OFT accuses Reckitt of market abuse

23rd February 2010

The Office of Fair Trading has said household manufacturer Reckitt Benckiser rigged the market to obtain a monopoly with its heartburn product Gaviscon.

If the company is found guilty it could have to pay the NHS up to £40 million, as it is accused of selling the product to the health service for three times the price of generic medication. In response to the OFT's accusation, Reckitt Benckiser (RB) said: "The OFT has stressed that no assumptions should be made at this stage. RB believes it competes fairly and within the letter and spirit of the law in all of our operations, and has co-operated fully with the OFT throughout its inquiry."

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: OFT accuses Reckitt of market abuse
Author: Jess Laurence
Article Id: 14157
Date Added: 23rd Feb 2010

Sources

The Financial Times
BBC News

Recent Related Articles

Large acute trust risks failing to meet financial target

CCG finances worsen

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016